Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
Applied Optoelectronics
AAOI
$11B
| $217K | ﹤0.01% |
14,109
-401,155
| -97% | -$8.09M |
|
4427
PUT
Vipshop
VIPS
$6.8B
| $217K | ﹤0.01% |
39,800
-787,000
| -95% | -$4.24M |
|
4428
PUT
Celanese
CE
$4.86B
| $216K | ﹤0.01% |
2,400
+1,500
| +167% | +$147K |
|
4429
CALL
Frontline
FRO
$9.02B
| $216K | ﹤0.01% |
39,000
+11,900
| +44% | +$77.7K |
|
|
GES
4430
CALL
DELISTED
Guess Inc
GES
| $216K | ﹤0.01% |
10,400
-4,300
| -29% | -$91.1K |
|
4431
Ooma
OOMA
$574M
| $216K | ﹤0.01% |
15,580
+8,535
| +121% | +$124K |
|
|
LORL
4432
CALL
DELISTED
Loral Space and Communications, Inc.
LORL
| $216K | ﹤0.01% |
+5,800
| New | +$249K |
|
|
EIDX
4433
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $216K | ﹤0.01% |
15,700
-1,816
| -10% | -$22.9K |
|
4434
CALL
Charles River Laboratories
CRL
$13.4B
| $215K | ﹤0.01% |
+1,900
| New | +$238K |
|
|
WSR
4435
DELISTED
Whitestone REIT
WSR
| $215K | ﹤0.01% |
17,478
-34,827
| -67% | -$472K |
|
|
CDK
4436
CALL
DELISTED
CDK Global, Inc.
CDK
| $215K | ﹤0.01% |
+4,500
| New | +$237K |
|
4437
Capitol Federal Financial
CFFN
$1.09B
| $214K | ﹤0.01% |
16,781
-35,967
| -68% | -$462K |
|
4438
Caesarstone
CSTE
$105M
| $214K | ﹤0.01% |
15,769
-9,460
| -37% | -$147K |
|
4439
PUT
FMC
FMC
$1.27B
| $214K | ﹤0.01% |
3,344
-3,805
| -53% | -$267K |
|
4440
CALL
Rambus
RMBS
$10.8B
| $214K | ﹤0.01% |
27,900
+9,700
| +53% | +$84.3K |
|
4441
PUT
Louisiana-Pacific
LPX
$5.18B
| $213K | ﹤0.01% |
9,600
+9,400
| +4,700% | +$213K |
|
|
GBT
4442
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $213K | ﹤0.01% |
5,200
-73,200
| -93% | -$2.74M |
|
|
FLIR
4443
CALL
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $213K | ﹤0.01% |
+4,900
| New | +$241K |
|
4444
Myers Industries
MYE
$1.25B
| $212K | ﹤0.01% |
14,048
-22,677
| -62% | -$372K |
|
|
REV
4445
CALL
DELISTED
Revlon, Inc.
REV
| $212K | ﹤0.01% |
8,400
+1,900
| +29% | +$46.9K |
|
4446
PUT
AutoNation
AN
$6.89B
| $211K | ﹤0.01% |
5,900
-8,300
| -58% | -$314K |
|
4447
CALL
Coca-Cola Europacific Partners
CCEP
$47.5B
| $211K | ﹤0.01% |
4,600
-1,700
| -27% | -$78.7K |
|
4448
PUT
MarketAxess Holdings
MKTX
$5.72B
| $211K | ﹤0.01% |
1,000
| – | – |
|
4449
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
| $211K | ﹤0.01% |
3,990
| – | – |
|
4450
Elanco Animal Health
ELAN
$11.2B
| $210K | ﹤0.01% |
6,653
+6,553
| +6,553% | +$215K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.